Publications by authors named "Christian Kurzeder"

74Publications

Early Modeled Longitudinal CA-125 Kinetics and Survival of Ovarian Cancer Patients: A GINECO AGO MRC CTU Study.

Clin Cancer Res 2019 09 1;25(17):5342-5350. Epub 2019 Apr 1.

Université de Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon-Sud, EMR UCBL/HCL 3738, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-3335DOI Listing
September 2019

[Impact of surgical approach on prognosis in early-stage cervical cancer].

Strahlenther Onkol 2019 03;195(3):274-276

MVZ im Fürstenberg-Karree, Institut für Zytologie Dysplasie, Hohenzollerndamm 123, 14199, Berlin, Deutschland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00066-019-01426-9DOI Listing
March 2019

Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) - Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare Facilities.

Geburtshilfe Frauenheilkd 2018 Nov 26;78(11):1089-1109. Epub 2018 Nov 26.

Klinik für Gynäkologie und Geburtshilfe, Universitätsmedizin Göttingen, Göttingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/a-0715-2964DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261739PMC
November 2018

Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) - Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer.

Geburtshilfe Frauenheilkd 2018 Oct 19;78(10):949-971. Epub 2018 Oct 19.

Klinik für Gynäkologie und Geburtshilfe, Universitätsmedizin Göttingen, Göttingen, Germany.

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/a-0713-1218
Publisher Site
http://dx.doi.org/10.1055/a-0713-1218DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195426PMC
October 2018

Die Rolle der onkoplastischen Chirurgie in der Behandlung des Mammakarzinoms.

Praxis (Bern 1994) 2017;106(25):1378-1382

1 Brustzentrum, Universitätsspital Basel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1024/1661-8157/a002852DOI Listing
January 2017

Current standards in oncoplastic breast conserving surgery.

Breast 2017 Aug 6;34 Suppl 1:S78-S81. Epub 2017 Jul 6.

Breast Center, University Hospital Basel, Basel, Switzerland; University of Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2017.06.033DOI Listing
August 2017

Serous Tubal Intraepithelial Carcinoma Associated With Extraovarian Metastases.

Int J Gynecol Cancer 2017 03;27(3):444-451

*Department of Gynecology and Gynecologic Oncology, Evangelische Huyssens-Stiftung, †Center for Pathology, Kliniken Essen-Mitte, Essen, Germany; and ‡Department of Gynecology and Gynecologic Oncology, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000920DOI Listing
March 2017

Intake of selective beta blockers has no impact on survival in patients with epithelial ovarian cancer.

Gynecol Oncol 2017 Jan 16;144(1):181-186. Epub 2016 Nov 16.

Department of Gynecology and Gynecologic Oncology; Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung, Essen, Germany.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258163156
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2016.11.012DOI Listing
January 2017

Phase II Study Evaluating PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecologic Sarcomas and Mixed Epithelial-Mesenchymal Tumors A Phase II Protocol of the Arbeitsgemeinschaft Gynaekologische Onkologie Study Group (AGO-GYN 7).

Int J Gynecol Cancer 2016 11;26(9):1636-1641

*Department of Gynecology & Gynecologic Oncology, Kliniken Essen-Mitte, Essen; †Department of Gynecology, Charité Medical University of Berlin, Berlin; ‡Coordinating Center for Clinical Trials, University Marburg; §Department of Gynecology, Gynecologic Endocrinology and Oncology, Philipps University Marburg, Marburg; ∥Department of Obstetrics and Gynecology, Johann Wolfgang Goethe-University, Frankfurt; ¶Department of Obstetrics and Gynecology, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck; #Department of Obstetrics and Gynecology, University of Duisburg-Essen, Essen; **Department of Gynecologic Oncology and Gynecology, Gynaekologicum Bremen, Bremen; ††Department of Obstetrics and Gynecology, Ludwig-Maximilians-University Munich, München; ‡‡Department of Obstetrics and Gynecology, Oberschwabenklinik Hospital St. Elisabeth Ravensburg, Ravensburg; §§Department of Obstetrics and Gynecology, University Hospital Ulm, Ulm; ∥∥Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg; ¶¶Department of Obstetrics and Gynecology, Carl Gustav Carus Technische University Dresden, Dresden; ##Gynecology Hannover, Hannover; ***Department of Obstetrics and Gynecology, Ev. Hospital Düsseldorf, Düsseldorf; †††Department of Obstetrics and Gynecology, University of Tübingen, Tübingen; and ‡‡‡Department of Obstetrics and Gynecology, University of Düsseldorf, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000831DOI Listing
November 2016

Impact of Abdominal Wall Metastases on Prognosis in Epithelial Ovarian Cancer.

Int J Gynecol Cancer 2016 11;26(9):1594-1600

*Department of Gynecology and Gynecologic Oncology, Evangelische Huyssens-Stiftung, Kliniken Essen-Mitte, Essen, Germany; †Department of Gynecology and Gynecologic Oncology, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria; and ‡Center for Pathology, Kliniken Essen-Mitte, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000826DOI Listing
November 2016

Prognostic Impact of Port-Site Metastasis After Diagnostic Laparoscopy for Epithelial Ovarian Cancer.

Ann Surg Oncol 2016 12 12;23(Suppl 5):834-840. Epub 2016 Jul 12.

Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-016-5415-9DOI Listing
December 2016

Double-Blind, Placebo-Controlled, Randomized Phase III Trial Evaluating Pertuzumab Combined With Chemotherapy for Low Tumor Human Epidermal Growth Factor Receptor 3 mRNA-Expressing Platinum-Resistant Ovarian Cancer (PENELOPE).

J Clin Oncol 2016 07 6;34(21):2516-25. Epub 2016 Jun 6.

Christian Kurzeder and Andreas du Bois, Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) and Kliniken Essen Mitte, Essen; Frederik Marmé, AGO and University Hospital Heidelberg, Heidelberg; Joern Rau and Carmen Schade-Brittinger, Coordinating Center for Clinical Trials, Philipps-University of Marburg, Marburg; Sven Mahner, AGO and University Medical Center Hamburg-Eppendorf, Hamburg; Sandra Polleis, AGO Study Group, Wiesbaden, Germany; Isabel Bover, Grupo Español de Investigación en Cáncer de Ovario (GEICO) and Hospital Son Llàtzer, Palma de Mallorca; Pilar Barretina-Ginesta, GEICO and Catalan Institute of Oncology, Girona; Josep M. del Campo, GEICO and Vall d'Hebron University Hospital, Barcelona; Antonio Gonzalez-Martin, GEICO and MD Anderson Cancer Center Spain, Madrid, Spain; Patricia Pautier, Group d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO) and Institut Gustave Roussy, Villejuif; Anne Floquet, GINECO and Institut Bergonié, Bordeaux, France; Nicoletta Colombo, Mario Negri Gynecologic Oncology Group and University of Milan Bicocca-European Institute of Oncology; Domenica Lorusso, Multicenter Italian Trials in Ovarian Cancer and Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, National Cancer Institute, Milan, Italy; Petronella Ottevanger, Dutch Gynecological Oncology Group and Radboud University Medical Center, Nijmegen, the Netherlands; Maria Bjurberg, Nordic Society of Gynecological Oncology and Department of Clinical Sciences, Skåne University Hospital, Lund University, Lund, Sweden; Christian Marth, AGO-Austria and Innsbruck Medical University, Innsbruck, Austria; Ignace Vergote, AGO and University Hospital Leuven, Leuven, Belgium; and Lydie Bastière-Truchot, Nicolas Martin, Mikkel Z. Oestergaard, and Astrid Kiermaier, F. Hoffmann-La Roche, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.0787DOI Listing
July 2016

The revised 2014 FIGO staging system for epithelial ovarian cancer: Is a subclassification into FIGO stage IVA and IVB justified?

Gynecol Oncol 2016 08 25;142(2):243-7. Epub 2016 May 25.

Department of Gynecology and Gynecologic Oncology, Evangelische Huyssens-Stiftung, Kliniken Essen-Mitte, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2016.05.021DOI Listing
August 2016

Pertuzumab Plus Chemotherapy for Platinum-Resistant Ovarian Cancer: Safety Run-in Results of the PENELOPE Trial.

Int J Gynecol Cancer 2016 06;26(5):898-905

* and Medical Oncology Department, MD Anderson Cancer Center, Madrid, Spain; †GINECO and Medical Oncology Department, Institut Gustave Roussy, Villejuif, France; ‡AGO and Department of Gynaecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; §Coordinating Center for Clinical Trials, Philipps-University of Marburg, Marburg, Germany; ∥MaNGO and Division of Medical Gynecologic Oncology, European Institute of Oncology and University of Milan-Bicocca, Milan, Italy; ¶DGOG and Department of MedicalOncology, Radboud University Medical Center, Nijmegen, The Netherlands; #GEICO and Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; **GINECO and Tenon Hospital AP-HP and Alliance Pour la Recherche en Cancérologie, France; ††AGO and Department of Gynecology and GynecologicOncology, Kliniken Essen Mitte, Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany; ‡‡MaNGO and Department of Clinical and Experimental Medicine, Division of Gynecology and Obstetrics, University of Pisa, Pisa, Italy; §§GEICO and Medical Oncology Department, Parc Taulí Sabadell-Hospital Universitari, Sabadell, Spain; ∥∥GINECO and Medical Oncology Department, Integrated Center for Oncology Nantes-Angers, Nantes, France; ¶¶AGO and National Centre for Tumour Diseases, Division of Gynaecologic Oncology, University Hospital Heidelberg, Heidelberg, Germany; ##GEICO and Department of Medical Oncology, Hospital Universitari Arnau de Vilanova, Lleida, Spain; ***Global Medical Affairs Biometrics, and †††Global Medical Affairs, F. Hoffmann-La Roche Ltd; and ‡‡‡Oncology Biomarker Development at Genentech Early Research and Development, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000695DOI Listing
June 2016

Pattern of and reason for postoperative residual disease in patients with advanced ovarian cancer following upfront radical debulking surgery.

Gynecol Oncol 2016 05 24;141(2):264-270. Epub 2016 Mar 24.

Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung, Germany; Department of Gynecology and Gynecologic Oncology, Horst-Schmidt Klinik Wiesbaden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2016.03.015DOI Listing
May 2016

The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications.

Arch Gynecol Obstet 2016 Apr 19;293(4):695-700. Epub 2016 Feb 19.

Klinik für Gynäkologie und Geburtsmedizin, Uniklinik RWTH Aachen, Pauwelsstr. 30, 52074, Aachen, Germany.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00404-016-4035-8
Publisher Site
http://dx.doi.org/10.1007/s00404-016-4035-8DOI Listing
April 2016

Temsirolimus in women with platinum-refractory/resistant ovarian cancer or advanced/recurrent endometrial carcinoma. A phase II study of the AGO-study group (AGO-GYN8).

Gynecol Oncol 2016 Mar 28;140(3):450-6. Epub 2015 Dec 28.

Universitätsklinikum Schleswig-Holstein, Campus Kiel, Klinik für Gynäkologie und Geburtshilfe, Arnold-Heller-Str. 3, Haus 24, 24105 Kiel, Germany,. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2015.12.025DOI Listing
March 2016

Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the uterine corpus and cervix.

Int J Gynecol Cancer 2014 Nov;24(9 Suppl 3):S90-5

*Saitama Medical University International Medical Center, Saitama, Japan (GOTIC); †Hyogo Cancer Center, Akashi, Japan (GOTIC); ‡Harvard Medical School, Boston, MA (RTOG); §Southern General Hospital, Glasgow, Lanarkshire, UK; ¶Beatson West of Scotland Cancer Centre, Glasgow, Scotland, UK (SGCTG); ∥Hospices Civils de Lyon, Lyon, France (GINECO); #Sunnybrook Regional Cancer Center, Toronto, Ontario, Canada (GOG); **Fondazione IRCCS National Cancer Institute of Milan, Milan, Italy (MITO); ††Kliniken Essen Mitte, Essen, Germany (AGO); ‡‡Seoul National University College of Medicine, Seoul, Korea (KGOG); §§Institut Claudius Regaud, Toulouse, France (GINECO); ¶¶Instituto Nazionale Tumori, Napoli, Italy (MITO); and ∥∥Prince of Wales Hospital, Sydney, Australia (ANZGOG).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000297DOI Listing
November 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for uterine serous carcinoma.

Int J Gynecol Cancer 2014 Nov;24(9 Suppl 3):S83-9

*Department of Obstetrics & Gynecology, JR Sapporo Hospital, Sapporo, Japan; †Department of Obstetrics & Gynecology, School of Medicine, Keio University, Tokyo; ‡Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA; §Department of Obstetrics and Gynecology, Ohio State University College of Medicine, Columbus, OH; ∥Centre Hospitalier de L'Université de Montréal, Montreal, Quebec, Canada; ¶Oncology Department, Christchurch Hospital, Canterbury, New Zealand; #Department of Clinical Oncology, Leiden University Medical Center, Leiden, the Netherlands; **Department Gynecology & Gynecologic Oncology, Kliniken Essen Mitte (KEM) (AGO), Essen, Germany; ††Norwegian Radium Hospital, Oslo, Norway; ‡‡Department of Obstetrics and Gynecology, Inje University Sanggye Paik Hospital, Seoul, South Korea; §§Department of Oncology and Hematology, Hôpitaux Universitaires de Strasbourg, Strasbourg, France; ∥∥Beatson West of Scotland Cancer Centre, Glasgow, Scotland; and ¶¶Department of Radiation Oncology, Stritch School of Medicine Loyola University, Chicago, IL.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ijgc/2014/11003/Gynecologic_Can
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/IGC.0000000000000264DOI Listing
November 2014

Incorporation of pazopanib in maintenance therapy of ovarian cancer.

J Clin Oncol 2014 Oct 15;32(30):3374-82. Epub 2014 Sep 15.

Andreas du Bois, Rainer Kimmig, Klaus H. Baumann, Christian Kurzeder, Ulrich Canzler, Philipp Harter, AGO Ovarian Cancer Study Group (AGO); Andreas du Bois, Christian Kurzeder, Philipp Harter, Kliniken Essen Mitte; Rainer Kimmig, West German Tumor Center, University of Duisburg-Essen, Essen; Joern Rau, Carmen Schade-Brittinger, Coordinating Center for Clinical Trials, Philipps-University of Marburg; Klaus H. Baumann, University of Marburg, Marburg; Ulrich Canzler, University Hospitals Carl Gustav Carus, Dresden, Germany; Anne Floquet, Isabelle Ray-Coquard, Marie-Ange Mouret-Reynier, Anne Lesoin, Eric Pujade-Lauraine, Groupe d'Investigateurs Nationaux pour l'Étude des Cancers Ovariens; Anne Floquet, Institut Bergonié, Bordeaux; Isabelle Ray-Coquard, Centre Léon Bérard, Lyon; Marie-Ange Mouret-Reynier, Centre Jean Perrin, Clermont-Ferrand; Anne Lesoin, Centre Oscar Lambret, Lille; Eric Pujade-Lauraine, Assistance Publique-Hôpitaux de Paris, Université Paris Descartes, Paris, France; Jae-Weon Kim, Jae-Hoon Kim, Korean Gynecologic Oncology Group; Jae-Weon Kim, Seoul National University; Jae-Hoon Kim, Yonsei University; Byoung-Gie Kim, Samsung Medical Center, Seoul, Republic of Korea; Josep M. del Campo, Ivan Diaz-Padilla, Spanish Ovarian Cancer Research Group; Josep M. del Campo, Vall d'Hebron University Hospital, Barcelona; Ivan Diaz-Padilla, Centro Integral Oncologico Clara Campal, HM Hospitales, Madrid, Spain; Michael Friedlander, Paul Vasey, Australian and New Zealand Gynecological Oncology Group; Michael Friedlander, The Prince of Wales Clinical School University of New South Wales, Randwick, New South Wales; Paul Vasey, Wesley Medical Centre, Auchenflower, Queensland, Australia; Sandro Pignata, Giovanni Scambia, Multicenter Italian Trials in Ovarian Cancer; Sandro Pignata, Istituto Nazionale Tumori Fondazione G. Pascale, Naples; Nicoletta Colombo, Mario Negri Gynecologic Oncology Group and University of Milan-Bicocca and European Institute of Oncology, Milan

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.7348DOI Listing
October 2014

Implementation of robot-assisted gynecologic surgery for patients with low and high BMI in a German gynecological cancer center.

Arch Gynecol Obstet 2014 Jul 15;290(1):143-8. Epub 2014 Feb 15.

Department of Obstetrics and Gynecology, University of Lund, Lund, Sweden,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00404-014-3169-9DOI Listing
July 2014

Prognostic and predictive value of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) score in surgery for recurrent ovarian cancer.

Gynecol Oncol 2014 Mar 23;132(3):537-41. Epub 2014 Jan 23.

Dept. of Gynecology & Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany; Dept. of Gynecology & Gynecologic Oncology, HSK, Dr. Horst Schmidt Klinik, Wiesbaden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2014.01.027DOI Listing
March 2014

Current and future options in the management and treatment of uterine sarcoma.

Ther Adv Med Oncol 2014 Jan;6(1):21-8

Department of Gynecology & Gynecologic Oncology, Kliniken Essen-Mitte, Essen Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758834013513314DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866995PMC
January 2014

Addition of vandetanib to pegylated liposomal doxorubicin (PLD) in patients with recurrent ovarian cancer. A randomized phase I/II study of the AGO Study Group (AGO-OVAR 2.13).

Invest New Drugs 2013 Dec 5;31(6):1499-504. Epub 2013 Sep 5.

Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Henricistr. 92, 45136, Essen, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-013-0011-3DOI Listing
December 2013

Impact of beta blocker medication in patients with platinum sensitive recurrent ovarian cancer-a combined analysis of 2 prospective multicenter trials by the AGO Study Group, NCIC-CTG and EORTC-GCG.

Gynecol Oncol 2013 Jun 15;129(3):463-6. Epub 2013 Mar 15.

Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung, Department of Gynecology and Gynecologic Oncology, Henricistrasse 92, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2013.03.007DOI Listing
June 2013

Bevacizumab in the treatment of ovarian cancer.

Adv Ther 2012 Sep 21;29(9):723-35. Epub 2012 Aug 21.

Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Evangelische Huyssen-Stiftung, Henricistrasse 92, 45136, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12325-012-0041-9DOI Listing
September 2012

Surgery for recurrent ovarian cancer.

Womens Health (Lond) 2011 Sep;7(5):529-35

Department of Gynecology & Gynecological Oncology, Kliniken Essen-Mitte, Huyssen-Stiftung/Knappschaft GmbH, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/whe.11.52DOI Listing
September 2011

B-cell-specific elements enhance sustained gene expression mediated by self-replicating extrachromosomal vectors.

Mol Med Rep 2010 Jul-Aug;3(4):689-92

Department of Child and Adolescent Psychiatry/Psychotherapy, University of Ulm Medical School, 89075 Ulm, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/mmr_00000318DOI Listing
October 2012

Focus on haematogenous dissemination of the malignant cystosarcoma phylloides: institutional experience.

Arch Gynecol Obstet 2011 Mar 11;283(3):591-6. Epub 2010 Nov 11.

Department of Gynecology and Obstetrics, University Hospital Ulm, Prittwitzstraße 43, 89075 Ulm, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00404-010-1746-0DOI Listing
March 2011

Impact of guideline conformity on breast cancer therapy: results of a 13-year retrospective cohort study.

Onkologie 2010 22;33(1-2):21-8. Epub 2010 Jan 22.

Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000264617DOI Listing
June 2010

Effects of guideline adherence in primary breast cancer--a 5-year multi-center cohort study of 3976 patients.

Breast 2010 Apr 1;19(2):120-7. Epub 2010 Feb 1.

Department of Gynecology and Obstetrics, University Hospital Ulm, University of Ulm Medical Center, Prittwitzstrasse 43, 89075 Ulm, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2009.12.006DOI Listing
April 2010

Comparison of early onset breast cancer patients to older premenopausal breast cancer patients.

Arch Gynecol Obstet 2010 Oct 3;282(4):427-32. Epub 2010 Jan 3.

Universitätsfrauenklinik Ulm, Prittwitzstrasse 43, 89075, Ulm, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00404-009-1339-yDOI Listing
October 2010

Tspan-1 is a tetraspanin preferentially expressed by mucinous and endometrioid subtypes of human ovarian carcinomas.

Cancer Lett 2009 Mar 18;275(2):198-203. Epub 2008 Nov 18.

IZKF Laboratory for Microarray Applications, University of Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2008.10.014DOI Listing
March 2009

Prognostic impact of satellite-lymphovascular space involvement in early-stage cervical cancer.

Ann Surg Oncol 2009 Jan 1;16(1):128-32. Epub 2008 Nov 1.

Department of Obstetrics and Gynecology, Ulm University Medical Center, Prittwitzstrasse 43, 89075, Ulm, Germany.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1245/s10434-008-0185
Web Search
http://www.springerlink.com/index/10.1245/s10434-008-0185-7
Publisher Site
http://dx.doi.org/10.1245/s10434-008-0185-7DOI Listing
January 2009

Pretreatment staging of cervical cancer: is imaging better than palpation?: Role of CT and MRI in preoperative staging of cervical cancer: single institution results for 255 patients.

Ann Surg Oncol 2008 Oct 12;15(10):2856-61. Epub 2008 Aug 12.

Department of Gynaecology and Obstetrics, University of Ulm, Prittwitzstrasse 43, 89075, Ulm, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-008-0088-7DOI Listing
October 2008

Stage IB endometrial cancer. Does lymphadenectomy replace adjuvant radiotherapy?

Strahlenther Onkol 2007 Nov;183(11):600-4

Department of Radiotherapy and Radiation Oncology, University Hospital, Ulm, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00066-007-1801-3DOI Listing
November 2007

CD9 promotes adeno-associated virus type 2 infection of mammary carcinoma cells with low cell surface expression of heparan sulphate proteoglycans.

Int J Mol Med 2007 Feb;19(2):325-33

Department of Obstetrics and Gynaecology, University of Ulm Medical School, Frauensteige 14, D-89075 Ulm, Germany.

View Article

Download full-text PDF

Source
February 2007

Chemotherapeutic agents enhance AAV2-mediated gene transfer into breast cancer cells promoting CD40 ligand-based immunotherapy.

J Cancer Res Clin Oncol 2006 Dec 23;132(12):787-94. Epub 2006 Jun 23.

Department of Obstetrics and Gynecology, University of Ulm Medical School, Frauensteige 14, 89075, Ulm, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-006-0127-3DOI Listing
December 2006

Molecular targets of ovarian carcinomas with acquired resistance to platinum/taxane chemotherapy.

Curr Cancer Drug Targets 2006 May;6(3):207-27

University of Ulm Medical School, Department of Obstetrics and Gynaecology, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/156800906776842975DOI Listing
May 2006

Immunotherapy and cancer vaccines in the management of breast cancer.

Curr Pharm Des 2005 ;11(27):3475-83

Department of Gynaecology and Obstetrics, University of Ulm Medical School, Ulm, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/138161205774414547DOI Listing
January 2006

Partial breast irradiation after breast-conserving surgery.

Strahlenther Onkol 2005 Jan;181(1):1-8

Department of Gynecology, University of Ulm, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00066-005-1394-7DOI Listing
January 2005

Efficient gene transfer of CD40 ligand into ovarian carcinoma cells with a recombinant adeno-associated virus vector.

Int J Oncol 2005 Jan;26(1):95-101

University of Ulm Medical School, Department of Obstetrics and Gynecology, Ulm, Germany.

View Article

Download full-text PDF

Source
January 2005

Progression of cervical carcinomas is associated with down-regulation of CD9 but strong local re-expression at sites of transendothelial invasion.

Clin Cancer Res 2003 Dec;9(17):6426-31

Department of Obstetrics and Gynecology, University of Ulm Medical School, Ulm, Germany.

View Article

Download full-text PDF

Source
December 2003

High level of transgene expression in primary chronic lymphocytic leukemia cells using helper-virus-free recombinant Epstein-Barr virus vectors.

Exp Hematol 2003 Feb;31(2):99-108

Medical Clinic III, University Hospital Grosshadern, Ludwig-Maximilians-University, Marchioninistrasse 15, D-81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0301-472x(02)01019-6DOI Listing
February 2003

Expression of tetraspanin adaptor proteins below defined threshold values is associated with in vitro invasiveness of mammary carcinoma cells.

Oncol Rep 2003 Mar-Apr;10(2):405-10

Department of Obstetrics and Gynecology, University of Ulm Medical School, Ulm, Germany.

View Article

Download full-text PDF

Source
July 2003

CD40L stimulation enhances the ability of conventional metaphase cytogenetics to detect chromosome aberrations in B-cell chronic lymphocytic leukaemia cells.

Br J Haematol 2002 Sep;118(4):968-75

GSF, National Research Center for Environment and Health, Genzentrum and Medizinische Klinik III, Klinikum der Universitaet Muenchen Grosshadern, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1365-2141.2002.03719.xDOI Listing
September 2002

New molecular targets of breast cancer therapy.

Strahlenther Onkol 2002 Mar;178(3):123-33

Department of Gynecology and Obstetrics, University of Ulm Medical School, Ulm, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00066-002-0957-0DOI Listing
March 2002